Clinical dosing schedule of inositol phosphate oligo(ethylene glycol) compounds
AssigneeVifor (International) AG
InventorMattias Emanuel Ivarsson
Life of this patent
Estimating the term…
Abstract
The invention relates to a dosing schedule for an inositol polyphosphate oligo(ethylene glycol) compound, or its pharmaceutically acceptable salt used in the treatment or prevention of a disease associated with formation of, and/or tissue exposure to, calcium salt crystals. The drug compound is administered at an interval of one week.
Claims8
A method for treatment of a disease associated with formation of, and/or tissue exposure to, calcium salt crystals, comprising administering to a subject in need thereof an inositol polyphosphate oligo (ethylene glycol) compound described by a compound selected from any one of the formulas Ia, Ib, or Ic:
- or the pharmaceutically acceptable salt of said compound
- wherein the inositol polyphosphate oligo (ethylene glycol) compound is administered to the subject at an interval of one week.
Dependencies are inferred from the claim text.